MARKET

KRRO

KRRO

Korro Bio, Inc.
NASDAQ
24.41
-0.25
-1.01%
Opening 12:30 03/14 EDT
OPEN
28.27
PREV CLOSE
24.66
HIGH
28.49
LOW
24.25
VOLUME
50.73K
TURNOVER
--
52 WEEK HIGH
98.00
52 WEEK LOW
18.50
MARKET CAP
228.68M
P/E (TTM)
-1.4329
1D
5D
1M
3M
1Y
5Y
1D
Korro Bio gets Orphan Drug Designation from FDA for its genetic disorder treatment
Seeking Alpha · 3h ago
Korro Bio's KRRO-110 Gets FDA Orphan Drug Designation
Dow Jones · 4h ago
KRRO-110 RECEIVES ORPHAN DRUG DESIGNATION FROM U.S. FDA FOR ALPHA-1 ANTITRYPSIN DEFICIENCY
Reuters · 4h ago
Weekly Report: what happened at KRRO last week (0303-0307)?
Weekly Report · 4d ago
Weekly Report: what happened at KRRO last week (0224-0228)?
Weekly Report · 03/03 09:05
Weekly Report: what happened at KRRO last week (0217-0221)?
Weekly Report · 02/24 09:05
Weekly Report: what happened at KRRO last week (0210-0214)?
Weekly Report · 02/17 09:05
Korro Bio Appoints Interim CFO Amid Medical Leave
TipRanks · 02/11 21:37
More
About KRRO
More
Korro Bio, Inc. is a biopharmaceutical company. The Company discovers, develops, and commercializes genetic medicines based on editing ribonucleic acid (RNA), enabling treatment of both rare and highly prevalent diseases. The Company is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, it is expanding the reach of genetic medicines. Its Oligonucleotide Promoted Editing of RNA (OPERA) is a foundational platform for RNA editing, which is designed to edit RNA in vivo by delivering an oligonucleotide guide that can target specific RNA sequences. The Company’s first development candidate, KRRO-110, is in development as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD), that has the potential to be disease-modifying and provide a differentiated therapeutic option.
Recently
Symbol
Price
%Change

Webull offers Korro Bio Inc stock information, including NASDAQ: KRRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KRRO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KRRO stock methods without spending real money on the virtual paper trading platform.